99 related articles for article (PubMed ID: 2155360)
1. Effect of p-mercuribenzoate on the subestimation of angiotensin-converting enzyme measurement during chick retina development.
Nunes-Mamede ML; De Mello FG; Martins AR
J Neurosci Methods; 1990 Jan; 31(1):7-11. PubMed ID: 2155360
[TBL] [Abstract][Full Text] [Related]
2. In ovo and in culture development of chick retinal angiotensin converting enzyme.
Nunes-Mamede ML; De Mello FG; Martins AR
Neurosci Lett; 1990 Feb; 109(1-2):174-9. PubMed ID: 2156192
[TBL] [Abstract][Full Text] [Related]
3. Standardization of a fluorimetric assay for the determination of tissue angiotensin-converting enzyme activity in rats.
Oliveira EM; Santos RA; Krieger JE
Braz J Med Biol Res; 2000 Jul; 33(7):755-64. PubMed ID: 10881050
[TBL] [Abstract][Full Text] [Related]
4. An improved fluorometric assay of rat serum and plasma converting enzyme.
Santos RA; Krieger EM; Greene LJ
Hypertension; 1985; 7(2):244-52. PubMed ID: 2984118
[TBL] [Abstract][Full Text] [Related]
5. Identification and properties of a peptidyl dipeptidase in the housefly, Musca domestica, that resembles mammalian angiotensin-converting enzyme.
Lamango NS; Isaac RE
Biochem J; 1994 May; 299 ( Pt 3)(Pt 3):651-7. PubMed ID: 8192653
[TBL] [Abstract][Full Text] [Related]
6. A continuous fluorescent assay for the determination of plasma and tissue angiotensin I-converting enzyme activity.
Alves MF; Araujo MC; Juliano MA; Oliveira EM; Krieger JE; Casarini DE; Juliano L; Carmona AK
Braz J Med Biol Res; 2005 Jun; 38(6):861-8. PubMed ID: 15933779
[TBL] [Abstract][Full Text] [Related]
7. Measuring angiotensin-I converting enzyme inhibitory activity by micro plate assays: comparison using marine cryptides and tentative threshold determinations with captopril and losartan.
Ben Henda Y; Labidi A; Arnaudin I; Bridiau N; Delatouche R; Maugard T; Piot JM; Sannier F; Thiéry V; Bordenave-Juchereau S
J Agric Food Chem; 2013 Nov; 61(45):10685-90. PubMed ID: 24131339
[TBL] [Abstract][Full Text] [Related]
8. Captopril ameliorates the decreased Na+,K(+)-ATPase activity in the retina of streptozotocin-induced diabetic rats.
Ottlecz A; Bensaoula T
Invest Ophthalmol Vis Sci; 1996 Jul; 37(8):1633-41. PubMed ID: 8675407
[TBL] [Abstract][Full Text] [Related]
9. Expression of angiotensin-converting enzyme (ACE) in the developing chicken retina.
Wheeler-Schilling TH; Sautter M; Guenther E; Kohler K
Exp Eye Res; 2001 Feb; 72(2):173-82. PubMed ID: 11161733
[TBL] [Abstract][Full Text] [Related]
10. Comparison of analytical methods to assay inhibitors of angiotensin I-converting enzyme.
Chen J; Wang Y; Ye R; Wu Y; Xia W
Food Chem; 2013 Dec; 141(4):3329-34. PubMed ID: 23993489
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin converting anzyme (ACE) activity in porcine ocular tissue: effects of diet and ACE inhibitors.
Geng L; Persson K; Nilsson SF
J Ocul Pharmacol Ther; 2003 Dec; 19(6):589-98. PubMed ID: 14733716
[TBL] [Abstract][Full Text] [Related]
12. Biochemical and ultrastructural studies in the neural retina and retinal pigment epithelium of STZ-diabetic rats: effect of captopril.
Bensaoula T; Ottlecz A
J Ocul Pharmacol Ther; 2001 Dec; 17(6):573-86. PubMed ID: 11777181
[TBL] [Abstract][Full Text] [Related]
13. Performance of two commonly used angiotensin-converting enzyme inhibition assays using FA-PGG and HHL as substrates.
Shalaby SM; Zakora M; Otte J
J Dairy Res; 2006 May; 73(2):178-86. PubMed ID: 16476177
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of angiotensin converting enzyme from sheep tissues by captopril, lisinopril and enalapril.
Udupa EG; Rao NM
Indian J Biochem Biophys; 1997 Dec; 34(6):524-8. PubMed ID: 9594434
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin-converting enzyme activity in retinas of streptozotocin-induced and Zucker diabetic rats. The effect of angiotensin II on Na+,K(+)-ATPase activity.
Ottlecz A; Bensaoula T; Eichberg J; Peterson RG
Invest Ophthalmol Vis Sci; 1996 Oct; 37(11):2157-64. PubMed ID: 8843902
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin-converting enzyme associated with Torpedo california electric organ membranes.
Altstein M; Dudai Y; Vogel Z
J Neurosci Res; 1987; 18(2):333-40. PubMed ID: 2826799
[TBL] [Abstract][Full Text] [Related]
17. Identification of angiotensin converting enzyme 2 in the rodent retina.
Tikellis C; Johnston CI; Forbes JM; Burns WC; Thomas MC; Lew RA; Yarski M; Smith AI; Cooper ME
Curr Eye Res; 2004 Dec; 29(6):419-27. PubMed ID: 15764086
[TBL] [Abstract][Full Text] [Related]
18. Internally quenched fluorogenic substrates for angiotensin I-converting enzyme.
Araujo MC; Melo RI; Del Nery E; Alves MF; Juliano MA; Casarini DE; Juliano L; Carmona AK
J Hypertens; 1999 May; 17(5):665-72. PubMed ID: 10403610
[TBL] [Abstract][Full Text] [Related]
19. Modification of the furanacryloyl-L-phenylalanylglycylglycine assay for determination of angiotensin-I-converting enzyme inhibitory activity.
Murray BA; Walsh DJ; FitzGerald RJ
J Biochem Biophys Methods; 2004 May; 59(2):127-37. PubMed ID: 15163524
[TBL] [Abstract][Full Text] [Related]
20. Screening for neuropeptide-metabolizing peptidases during the differentiation of chick embryo retina.
Martins AR; De Mello FG
Brain Res; 1985 Jul; 353(1):147-51. PubMed ID: 2992715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
